Clinical Trials Sponsored by Acrotech Biopharma

Total 1459 results

TJ Biopharma Co., Ltd.

Active, not recruiting

TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma | Multiple Myeloma in Relapse

China, Taiwan
TJ Biopharma Co., Ltd.

Active, not recruiting

TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma | Multiple Myeloma in Relapse

China, Taiwan
HighTide Biopharma Pty Ltd

Active, not recruiting

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes (CENTRICITY)

Type 2 Diabetes | Nonalcoholic Steatohepatitis (NASH)

United States, China, Hong Kong
Shanghai Zhimeng Biopharma, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants in Australia

Healthy Volunteers

Australia
Zenas BioPharma (USA), LLC

Active, not recruiting

Study of ZB001 in Chinese Patients With Thyroid Eye Disease

Thyroid Eye Disease

China
AEON Biopharma, Inc.
PPD

Active, not recruiting

Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

Migraine

United States, Australia, Canada
AEON Biopharma, Inc.
PPD

Completed

Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia

Cervical Dystonia

United States
Zenas BioPharma (USA), LLC

Completed

A Safety, Tolerability and Pharmacokinetics Study of ZB001 in Healthy Subjects

Healthy Volunteers

China
Reistone Biopharma Company Limited

Active, not recruiting

Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy

Primary Membranous Nephropathy

China
Reistone Biopharma Company Limited

Completed

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

China, Canada
First Wave BioPharma, Inc.

Active, not recruiting

Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection (RESERVOIR)

Covid19

United States, Ukraine, India
HighTide Biopharma Pty Ltd

Completed

A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia

Hypercholesterolemia

Australia
Elpiscience (Suzhou) Biopharma, Ltd.

Active, not recruiting

A Study of ES104 in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Tanvex BioPharma USA, Inc.

Completed

Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03

Breast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast Cancer

Belarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
ARCA Biopharma, Inc.
Medtronic

Completed

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure (GENETIC-AF)

Current or Recent History of Atrial Fibrillation

United States, Canada, Hungary, Netherlands, Poland, Serbia
Mereo BioPharma
Syneos Health

Completed

A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. (ASTRAEUS)

Emphysema | Alpha 1-Antitrypsin Deficiency | COPD

United Kingdom, Belgium, United States, Denmark, Canada, Sweden, Poland, Spain
HighTide Biopharma Pty Ltd

Completed

A POC and Dose-Ranging Study of HTD1801 in PSC Patients

Primary Sclerosing Cholangitis (PSC)

United States, Canada
Matinas Biopharma, Inc
Covance

Withdrawn

Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL (AMPLIFY)

Severe Hypertriglyceridemia
Boryung Biopharma Co., Ltd.

Completed

To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children

Tetanus | Diphtheria

Korea, Republic of
Seagen Inc.
Array BioPharma

Completed

A Study of ARRY-380 in Patients With Advanced HER2+ Cancer

Cancer

Canada, United States
CTI BioPharma
SGS S.A.

Completed

Determine Pacritinib Pharmacokinetics in Impaired Hepatic Patients and Healthy Subjects

Myelofibrosis

Moldova, Republic of, Germany
Helix BioPharma Corporation
Theradex

Completed

A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC

Non-Small Cell Lung Cancer

United States
Pfizer
Novartis; Keyrus Biopharma

Completed

OPALINE : A Study Of Morbidity And Mortality At 2 Years (OPALINE)

Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive

France
Genor Biopharma Co., Ltd.

Completed

Clinical Trial of Comparative Study of GB221 Pharmacokinetics

Metastatic Breast Cancer

Australia
Genor Biopharma Co., Ltd.

Unknown

A Study to Evaluate the Safety and Tolerability of Multiple Doses of Gerilimzumab in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

China
Genor Biopharma Co., Ltd.

Unknown

Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection

HER-2-positive Advanced Breast Cancer

China
Alios Biopharma Inc.
Alexion

Completed

A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers

Chronic Hepatitis C

France
Matinas BioPharma Nanotechnologies, Inc.

Withdrawn

Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis

Vulvovaginitis | Candidiasis, Vulvovaginal | Vulvovaginal Candidiases | Yeast Infection | Yeast Infection Vaginal

United States
Northumbria University
Pronova BioPharma

Completed

The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood

Cognitive Function

United Kingdom
Advagene Biopharma Co. Ltd.

Completed

A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult

Influenza Infection

Taiwan
CTI BioPharma
SGS S.A.

Completed

PK of Pacritinib in Patients With Mild, Moderate, Severe Renal Impairment and ESRD Compared to Healthy Subjects

Myelofibrosis

Moldova, Republic of, Germany, Romania
Haihe Biopharma Co., Ltd.

Unknown

A Phase I Study of SCC244

Advanced Solid Tumor

China
Theravance Biopharma
Alfasigma S.p.A.

Completed

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

Gastroparesis

United States
Northumbria University
Pronova BioPharma

Completed

Plasma Diurnal Variation in and Absorption of EPA and DHA

Lipid Absorption and Metabolism

United Kingdom
Immune Response BioPharma, Inc.

Unknown

REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study (RAISE)

HIV

United States
HanAll BioPharma Co., Ltd.

Completed

Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia

Essential Hypertension | Hyperlipidemia

Korea, Republic of
HanAll BioPharma Co., Ltd.

Completed

Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

Hypertension

Korea, Republic of
HanAll BioPharma Co., Ltd.

Completed

A Phase 1b/2a, Open-label,Randomized, Safety, Tolerability, Dose Finding, PK/PD, and Preliminary Efficacy Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C

Chronic Hepatitis C Infection | Genotype 1

United States
HanAll BioPharma Co., Ltd.

Completed

A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects

Hypertension | Hyperlipidemia

United States
ApoPharma

Completed

Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects

Asymptomatic HIV Infection

South Africa
ApoPharma

Completed

Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers

Healthy

Canada
ApoPharma

Completed

A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia

Friedreich's Ataxia

Belgium, France, Italy, Spain
ApoPharma

Completed

A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia

Friedreich's Ataxia

Canada, Australia, Belgium, France, Italy, Spain
ApoPharma

Completed

Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients

Iron Overload

Egypt, Indonesia, Malaysia
Array Biopharma, now a wholly owned subsidiary...

Completed

A Safety Study of ARRY-371797 in Healthy Subjects

Healthy

United States
Array Biopharma, now a wholly owned subsidiary...

Withdrawn

Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC

Non-Small Cell Lung Cancer

United States
Array Biopharma, now a wholly owned subsidiary...

Completed

A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer

Advanced Cancer

United States
Array Biopharma, now a wholly owned subsidiary...

Completed

A Safety Study of ARRY-300 in Healthy Subjects

Healthy

United States
Array Biopharma, now a wholly owned subsidiary...

Completed

A Safety Study of ARRY-502 in Healthy Subjects

Healthy

United States
Array Biopharma, now a wholly owned subsidiary...

Completed

A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors

Advanced Solid Tumor

Japan

Clinical Trials Sponsored by Acrotech Biopharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations